0 Bedömningar
ID

33312

Beskrivning

Study ID: 104065 Clinical Study ID: 104065 Study Title: Immune memory of GSK's DTPw-HBV/Hib vaccine by giving Plain PRP polysaccharide at 10 mths. Immuno & reacto of a booster dose of DTPw-HBV/Hib or DTPw-HBV or DTPw-HBV+Hib at 15-18 mths in infants previously primed with DTPw-HBV/Hib Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00169442  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completet Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine (KFT) Trade Name: Zilbrix/Hib Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis

Nyckelord

Versioner (2)
  1. 2018-12-05 2018-12-05 -
  2. 2018-12-05 2018-12-05 -
Rättsinnehavare

GSK group of companies

Uppladdad den

5 december 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Immune memory of Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine at infants (15 to 18 mths)

    Engelsk

    Visit 1: Exclusion Criteria

    1 Formulär  
    Administrative data
    Beskrivning

    Administrative data

    Date of Visit
    Beskrivning

    Date of Visit

    Datatyp

    date

    Subject Number
    Beskrivning

    Subject Number

    Datatyp

    integer

    Eligibility check
    Beskrivning

    Eligibility check

    Did the subject meet all the entry criteria?
    Beskrivning

    Did the subject meet all the entry criteria?

    Datatyp

    boolean

    If No, please tick all boxes corresponding to violations of any inclusion/exclusion criteria
    Beskrivning

    Do not enter the subject into the study if he/she failed any inclusion or exclusion criteria listed below

    Datatyp

    text

    Exclusion Criteria
    Beskrivning

    Exclusion Criteria

    For subjects receiving Plain PRP followed by DTPw-HBV Kft:
    Beskrivning

    tick "Yes" for any of the exclusion criteria that disqualified the subject from entry

    Datatyp

    text

    Use of investigational or non-registered product other than study vaccine within 30 days preceding administration of the study vaccine, or planned use during the study period.
    Beskrivning

    Use of investigational or non-registered product other than study vaccine within 30 days preceding administration of the study vaccine, or planned use during the study period.

    Datatyp

    boolean

    Chronic administration (more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to administration of the study vaccine.
    Beskrivning

    For corticosteroids, this will mean prednisone, or equivalent >=0.5 mg/kg/day. Inhaled and topical steroids are allowed

    Datatyp

    boolean

    Planned administration/administration of vaccine not foreseen by the study protocol during the 30-day period starting before and ending 30 days after administration of the study vaccine with the exception of oral polio vaccine.
    Beskrivning

    Planned administration/administration of vaccine not foreseen by the study protocol during the 30-day period starting before and ending 30 days after administration of the study vaccine with the exception of oral polio vaccine.

    Datatyp

    boolean

    Previous booster vaccination against diphteria, tetanus, pertussis, hepatitis B and/or Hib disease since the conclusion of the study DTPw=Hib Kft-001.
    Beskrivning

    Previous booster vaccination against diphteria, tetanus, pertussis, hepatitis B and/or Hib disease since the conclusion of the study DTPw=Hib Kft-001.

    Datatyp

    boolean

    History of dyphtheria, tetanus, petrussis, hepatits B and/or Kft-001
    Beskrivning

    History of dyphtheria, tetanus, petrussis, hepatits B and/or Kft-001

    Datatyp

    boolean

    Known exposure to diphtheria,tetanus, pertussis, hepatitis B and/or Hib disease
    Beskrivning

    Known exposure to diphtheria,tetanus, pertussis, hepatitis B and/or Hib disease

    Datatyp

    boolean

    Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination (no laboratory testing is required).
    Beskrivning

    Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination (no laboratory testing is required).

    Datatyp

    boolean

    A family history of congenital or hereditary immunodeficiency.
    Beskrivning

    A family history of congenital or hereditary immunodeficiency.

    Datatyp

    boolean

    History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
    Beskrivning

    History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.

    Datatyp

    boolean

    Major congenital defects or serious chronic illness.
    Beskrivning

    Major congenital defects or serious chronic illness.

    Datatyp

    boolean

    History of any neurologic disorders or seizures.
    Beskrivning

    Subject who only had a single, uncomplicated febrile convulsion in the past can be included

    Datatyp

    boolean

    Acute disease at the time of enrollment.
    Beskrivning

    Acute disease - the presence of a moderate or severe illness with or without fever; All vaccines can be administered to persons with a minor illness such as diarrhoea, mild upper respiratory infection with or without low-grade febrile illness, i.e. axillary t° <37.5°C/rectal t° <38°C

    Datatyp

    boolean

    Administration of immunoglobulins and/or any blood products within the three months preceding administration of the study vaccine or planned administration during the study period.
    Beskrivning

    Administration of immunoglobulins and/or any blood products within the three months preceding administration of the study vaccine or planned administration during the study period.

    Datatyp

    boolean

    Other conditions which in the opinion of the investigator may potentially interfere with interpretation of study outcomes.
    Beskrivning

    Other conditions which in the opinion of the investigator may potentially interfere with interpretation of study outcomes.

    Datatyp

    boolean

    Specify other conditions.
    Beskrivning

    if necessary

    Datatyp

    text

    Adverse events
    Beskrivning

    one of the following AE that constitute contraindications or precaution to further administration of DTP vaccine, having occurred after previous administration of DTP vaccine

    Datatyp

    text

    Tillbaka till toppen

    Similar models

    Visit 1: Exclusion Criteria

    1 Formulär
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Administrative data
    Date of Visit
    Item
    Date of Visit
    date
    Subject Number
    Item
    Subject Number
    integer
    Item Group
    Eligibility check
    Did the subject meet all the entry criteria?
    Item
    Did the subject meet all the entry criteria?
    boolean
    If No, please tick all boxes corresponding to violations of any inclusion/exclusion criteria
    Item
    If No, please tick all boxes corresponding to violations of any inclusion/exclusion criteria
    text
    Item Group
    Exclusion Criteria
    For subjects receiving Plain PRP followed by DTPw-HBV Kft:
    Item
    For subjects receiving Plain PRP followed by DTPw-HBV Kft:
    text
    Use of investigational or non-registered product other than study vaccine within 30 days preceding administration of the study vaccine, or planned use during the study period.
    Item
    Use of investigational or non-registered product other than study vaccine within 30 days preceding administration of the study vaccine, or planned use during the study period.
    boolean
    Chronic administration (more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to administration of the study vaccine.
    Item
    Chronic administration (more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to administration of the study vaccine.
    boolean
    Planned administration/administration of vaccine not foreseen by the study protocol during the 30-day period starting before and ending 30 days after administration of the study vaccine with the exception of oral polio vaccine.
    Item
    Planned administration/administration of vaccine not foreseen by the study protocol during the 30-day period starting before and ending 30 days after administration of the study vaccine with the exception of oral polio vaccine.
    boolean
    Previous booster vaccination against diphteria, tetanus, pertussis, hepatitis B and/or Hib disease since the conclusion of the study DTPw=Hib Kft-001.
    Item
    Previous booster vaccination against diphteria, tetanus, pertussis, hepatitis B and/or Hib disease since the conclusion of the study DTPw=Hib Kft-001.
    boolean
    History of dyphtheria, tetanus, petrussis, hepatits B and/or Kft-001
    Item
    History of dyphtheria, tetanus, petrussis, hepatits B and/or Kft-001
    boolean
    Known exposure to diphtheria,tetanus, pertussis, hepatitis B and/or Hib disease
    Item
    Known exposure to diphtheria,tetanus, pertussis, hepatitis B and/or Hib disease
    boolean
    Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination (no laboratory testing is required).
    Item
    Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination (no laboratory testing is required).
    boolean
    A family history of congenital or hereditary immunodeficiency.
    Item
    A family history of congenital or hereditary immunodeficiency.
    boolean
    History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
    Item
    History of allergic disease or reactions likely to be exacerbated by any component of the vaccine.
    boolean
    Major congenital defects or serious chronic illness.
    Item
    Major congenital defects or serious chronic illness.
    boolean
    History of any neurologic disorders or seizures.
    Item
    History of any neurologic disorders or seizures.
    boolean
    Acute disease at the time of enrollment.
    Item
    Acute disease at the time of enrollment.
    boolean
    Administration of immunoglobulins and/or any blood products within the three months preceding administration of the study vaccine or planned administration during the study period.
    Item
    Administration of immunoglobulins and/or any blood products within the three months preceding administration of the study vaccine or planned administration during the study period.
    boolean
    Other conditions which in the opinion of the investigator may potentially interfere with interpretation of study outcomes.
    Item
    Other conditions which in the opinion of the investigator may potentially interfere with interpretation of study outcomes.
    boolean
    Specify other conditions.
    Item
    Specify other conditions.
    text
    Item
    Adverse events
    text
    Adverse events
    Code List
    Adverse events
    CL Item
    Hypersensitivity to any component of the vaccine, or signs of hypersensitivity after previous administration of diphtheria, tetanus, pertussis, hepatitis B and Hib vaccines (1)
    CL Item
    Encephalopathy (not due to another identifiable cause): acute, severe central nervous system disorder occurring within 7 days following vaccination->major alterations in consciousness, unresponsiveness, generalised or focal seizures that persist more than a few hours, with failure to recover within 24 hours (2)
    CL Item
    Axillary temperature of ≥ 40°C/rectal temperature ≥ 40.5°C within 48 hrs of vaccination (3)
    CL Item
    Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hrs of vaccination (4)
    CL Item
    Persistent, inconsolable crying lasting ≥3 hrs, occurring within 48 hrs of vaccination (5)
    CL Item
    Convulsions with or without fever, occuring within 3 days of vaccination (6)
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial